Edwards Lifesciences Corp - EW
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | SVP, Corporate Controller | F | D | 101.0 | 105.8 | 10,685.8 | 14,605.78 | View | |
| Nov 10, 2026 | CVP, TAVR | M | D | 619.0 | 0.0 | 0.0 | 2,476.0 | View | |
| Nov 10, 2026 | CVP, TAVR | S | D | 619.0 | 104.25 | 64,530.75 | 40,033.91 | View | |
| Nov 10, 2026 | CVP, TAVR | M | A | 619.0 | 72.68 | 44,988.92 | 40,652.91 | View | |
| Nov 09, 2026 | CEO | M | D | 23,100.0 | 0.0 | 0.0 | 23,100.0 | View | |
| Nov 09, 2026 | CEO | S | D | 13,916.0 | 102.7803 | 1,430,290.65 | 98,845.0 | View | |
| Nov 09, 2026 | CEO | S | D | 9,184.0 | 103.3851 | 949,488.76 | 112,761.0 | View | |
| Nov 09, 2026 | CEO | M | A | 23,100.0 | 72.68 | 1,678,908.0 | 121,945.0 | View | |
| Nov 09, 2026 | CVP,Strategy/Corp Development | M | D | 48,900.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 09, 2026 | CVP,Strategy/Corp Development | S | D | 48,900.0 | 103.0534 | 5,039,311.26 | 22,798.25 | View | |
| Nov 09, 2026 | CVP,Strategy/Corp Development | M | A | 48,900.0 | 72.68 | 3,554,052.0 | 71,698.25 | View | |
| Oct 08, 2026 | CVP, TAVR | M | D | 619.0 | 0.0 | 0.0 | 3,095.0 | View | |
| Oct 08, 2026 | CVP, TAVR | S | D | 619.0 | 85.65 | 53,017.35 | 40,033.91 | View | |
| Oct 08, 2026 | CVP, TAVR | M | A | 619.0 | 72.68 | 44,988.92 | 40,652.91 | View | |
| Sep 14, 2026 | CVP, JAPAC | F | D | 568.0 | 84.37 | 47,922.16 | 19,370.56 | View | |
| Sep 14, 2026 | CVP, JAPAC | F | D | 355.0 | 86.77 | 30,803.35 | 19,938.56 | View | |
| Sep 14, 2026 | SVP, Corporate Controller | F | D | 253.0 | 84.37 | 21,345.61 | 14,615.41 | View | |
| Sep 11, 2026 | CVP, TMTT, Surgical & IHFM | F | D | 398.0 | 86.77 | 34,534.46 | 43,926.0 | View | |
| Sep 11, 2026 | CVP, TAVR | M | D | 619.0 | 0.0 | 0.0 | 3,714.0 | View | |
| Sep 11, 2026 | CVP, TAVR | S | D | 619.0 | 87.51 | 54,168.69 | 40,033.91 | View | |
| Sep 11, 2026 | CVP, TAVR | M | A | 619.0 | 72.68 | 44,988.92 | 40,652.91 | View | |
| Aug 31, 2026 | SVP, Corporate Controller | S | D | 544.0 | 91.055 | 49,533.92 | 14,868.41 | View | |
| Aug 28, 2026 | CVP, EMEACLA | S | D | 2,644.0 | 89.98 | 237,907.12 | 17,984.0 | View | |
| Aug 26, 2026 | CVP, TMTT, Surgical & IHFM | M | D | 31,800.0 | 0.0 | 0.0 | 0.0 | View | |
| Aug 26, 2026 | CVP, TMTT, Surgical & IHFM | S | D | 30,646.0 | 90.9922 | 2,788,546.96 | 44,324.0 | View | |
| Aug 26, 2026 | CVP, TMTT, Surgical & IHFM | S | D | 1,154.0 | 91.7614 | 105,892.66 | 74,970.0 | View | |
| Aug 26, 2026 | CVP, TMTT, Surgical & IHFM | M | A | 31,800.0 | 72.68 | 2,311,224.0 | 76,124.0 | View | |
| Aug 26, 2026 | CVP, JAPAC | S | D | 1,240.0 | 91.465 | 113,416.6 | 20,293.56 | View | |
| Aug 11, 2026 | CVP, TAVR | M | D | 619.0 | 0.0 | 0.0 | 4,333.0 | View | |
| Aug 11, 2026 | CVP, TAVR | S | D | 619.0 | 92.03 | 56,966.57 | 40,033.91 | View | |
| Aug 11, 2026 | CVP, TAVR | M | A | 619.0 | 72.68 | 44,988.92 | 40,652.91 | View | |
| Jul 30, 2026 | CVP, JAPAC | S | D | 146.31 | 86.0338 | 12,587.84 | 21,533.56 | View | |
| Jul 28, 2026 | CVP, JAPAC | M | D | 9,628.0 | 0.0 | 0.0 | 9,628.0 | View | |
| Jul 28, 2026 | CVP, JAPAC | S | D | 9,628.0 | 85.06 | 818,957.68 | 21,679.87 | View | |
| Jul 28, 2026 | CVP, JAPAC | M | A | 9,628.0 | 74.02 | 712,664.56 | 31,307.87 | View | |
| Jul 27, 2026 | CEO | S | D | 2,920.55 | 83.9342 | 245,134.12 | 8,915.65 | View | |
| Jul 27, 2026 | CEO | G | A | 319.65 | 0.0 | 0.0 | 11,836.2 | View | |
| Jul 27, 2026 | CEO | G | D | 319.65 | 0.0 | 0.0 | 98,845.0 | View | |
| Jul 13, 2026 | CVP, EMEACLA | F | D | 109.0 | 92.21 | 10,050.89 | 20,628.0 | View | |
| Jul 10, 2026 | CVP, Chief Financial Officer | A | A | 12,325.0 | 0.0 | 0.0 | 12,325.0 | View | |
| Jul 10, 2026 | CVP, Chief Financial Officer | A | A | 61,800.0 | 0.0 | 0.0 | 61,800.0 | View | |
| Jul 10, 2026 | CVP, Chief Financial Officer | A | A | 12,325.0 | 0.0 | 0.0 | 99,920.0 | View | |
| Jul 10, 2026 | CVP, Chief Financial Officer | A | A | 87,595.0 | 0.0 | 0.0 | 87,595.0 | View | |
| Jul 10, 2026 | CVP, TAVR | M | D | 619.0 | 0.0 | 0.0 | 4,952.0 | View | |
| Jul 10, 2026 | CVP, TAVR | S | D | 619.0 | 91.7 | 56,762.3 | 40,033.91 | View | |
| Jul 10, 2026 | CVP, TAVR | M | A | 619.0 | 72.68 | 44,988.92 | 40,652.91 | View | |
| Jul 07, 2026 | CVP, TAVR | F | D | 377.0 | 95.18 | 35,882.86 | 40,033.91 | View | |
| Jun 30, 2026 | CVP, TAVR | M | D | 619.0 | 0.0 | 0.0 | 5,571.0 | View | |
| Jun 30, 2026 | CVP, TAVR | S | D | 619.0 | 91.4002 | 56,576.72 | 40,410.91 | View | |
| Jun 30, 2026 | CVP, TAVR | M | A | 619.0 | 72.68 | 44,988.92 | 41,029.91 | View | |
| Jun 17, 2026 | CEO | S | D | 523.0 | 87.92 | 45,982.16 | 11,516.55 | View | |
| May 29, 2026 | SVP, Corporate Controller | S | D | 567.53 | 86.08 | 48,852.69 | 15,334.09 | View | |
| May 27, 2026 | CVP,Strategy/Corp Development | S | D | 23,145.0 | 86.4201 | 2,000,193.21 | 98,611.0 | View | |
| May 22, 2026 | CVP, TMTT & Surgical | S | D | 1,500.0 | 84.6035 | 126,905.25 | 44,324.0 | View |